Skip to main content

GOLDMAN SACHS GROUP INC

Position in CRDL — Cardiol Therapeutics Inc.

CIK 886982 NEW YORK, NY

Position in CRDL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$353,934
-$94,806 QoQ
Shares Held
333,900
+0.5% QoQ
Ownership
0.286%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 52 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRDL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. CRDL ranks #50 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRDL

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $353,934 333,900
2026-03-31 $448,740 332,400
2025-12-31 $313,389 328,500
2025-09-30 $344,326 321,800
2025-06-30 $78,200 57,500
2025-03-31 $38,024 39,200
2024-12-31 $45,952 35,900
2024-09-30 $71,478 36,100
2024-06-30 $47,470 23,500
2024-03-31 $42,535 23,500
2023-12-31 $19,810 23,500
2023-09-30 $21,032 23,500
2023-06-30 $20,915 23,500
2023-03-31 $11,980 24,600
2022-12-31 $51,765 101,500
2022-03-31 $100,368 65,600
2021-12-31 $233,285 126,100
2021-09-30 $79,265 19,100